UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14-A
(Rule
14A-101)
PROXY
STATEMENT PURSUANT TO SECTION 14(a)
OF
THE SECURITIES AND EXCHANGE ACT OF 1934
Filed by
the Registrant
þ
Filed by
a Party other than the Registrant
o
Check the
appropriate box:
o
Preliminary Proxy
Statement
o
Confidential,
For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o
Definitive
Proxy Statement
þ
Definitive
Additional Materials
o
Soliciting
Materials Pursuant to Section 240.14a.12
LCA-Vision
Inc.
(Name
of Registrant as Specified in its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
þ
No fee
required.
o
Fee computed on
table below per Exchange Act Rules 14a-6(i)(1) and 0-11
1)
|
Title
of each class of securities to which the transaction applies:
__________________________________________________________________
|
2)
|
Aggregate
number of securities to which transaction applies:
__________________________________________________________________
|
3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
__________________________________________________________________
|
4)
|
Proposed
maximum aggregate value of transaction:
__________________________________________________________________
|
o
Fee paid
previously with preliminary materials
o
|
Check
box if any part of the fee is offset by Exchange Act Rule 0-11(a)(2) and
identify the filing for which the offsetting fee was previously
paid. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its
filing.
|
1.
|
Amount
Previously Paid:
__________________________________________________________________
|
2.
|
Form,
Schedule or Registration No.:
__________________________________________________________________
|
3.
|
Filing
Party:
__________________________________________________________________
|
4.
|
Date
Filed:
__________________________________________________________________
|
On March
18, 2009, LCA-Vision Inc. issued the following press release.
LCA-Vision’s
Medical Advisory Board Voices Support for Current Management
CINCINNATI (March 18, 2009)
–
LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction
services under the Lasik
Plus
®
brand,
announces that its 11-member Medical Advisory Board has expressed unanimous
support for LCA-Vision management’s actions to address concerns raised by the
Company’s surgeons in June 2008. The full text of the Medical
Advisory Board’s letter to LCA-Vision Chairman E. Anthony Woods appears
below:
March 16,
2009
Dear Mr.
Woods:
The
Medical Advisory Board unanimously recognizes and unanimously supports the
efforts taken by current management to address the issues raised by us this past
June. We brought our concerns to your attention to help restore
Lasik
Plus
to its
rightful industry leadership position. The actions taken by
management since our meetings have addressed many of our concerns and are, in
our opinion, strong steps in the right direction. These actions
include, but are not limited to: more surgeon involvement with management,
significant strategic planning and changes involving marketing and operations,
and more openness and transparency at all levels.
We
greatly appreciate what the management team has done over the past 8 months. We
strongly support the initiatives that are evolving and the growing collaborative
efforts to make Lasik
Plus
a stronger enterprise.
We anticipate these actions are the foundation of a true partnership and look
forward to working with management to achieve what is best for our patients and
the Company. Together we can use these difficult economic times to
strengthen the Lasik
Plus
position; together we
can ensure a bright future.
Respectfully,
The
Medical Advisory Board of LCA Vision, Inc.
Steven
Straus, LCA-Vision chief executive officer, said, “The Company is benefiting
from our strengthened partnership with our Medical Advisory Board and surgeons
across our Lasik
Plus
®
vision centers. The surgeons’ input is extremely valuable in helping
us navigate through a challenging environment that has significantly impacted
our business and our industry. We look forward to building further
upon this foundation as we work together toward a prosperous
future.”
************************
Due to
the nature of the Consent process, your voting instruction is extremely
important and time sensitive. LCA-Vision urges all stockholders to
vote their GOLD cards to REVOKE CONSENT on all three
proposals. Please discard any proxy card that you receive from the
Joffe Group. If you have already voted to consent and wish to change
your vote, you have every right to revoke your consent and vote the GOLD
proxy. Only the latest dated card counts.
LCA-Vision
filed its Definitive Consent Revocation Statement (“Consent Revocation
Statement”) with the Securities and Exchange Commission on Monday, February 9,
2009, and copies of the Consent Revocation Statement with a GOLD Consent
Revocation Card were mailed to stockholders beginning February 10,
2009. The Consent Revocation Statement can be obtained immediately
from the SEC’s website at the following link:
http://idea.sec.gov/Archives/edgar/data/1003130/000114420409006021/v139094_defc14a.htm
or from
the Investor Relations section of the Company’s website at
www.lasikplus.com
and
www.lca-vision.com
. Copies
of the Consent Revocation Statement and consent revocation card may also be
obtained from Georgeson Inc.
Additional
Information:
Georgeson
Inc. has been retained by LCA-Vision as consent revocation solicitation agent.
Stockholders with questions are encouraged to call Georgeson toll-free
1-800-457-0109
. Copies of the
Company’s Consent Revocation Statement, and any other documents filed by
LCA-Vision with the SEC in connection with the consent solicitation can be
obtained free of charge from the SEC’s website at
www.sec.gov
, from the
Company’s website at www.lasikplus.com and www.lca-vision.com, or from
Georgeson.
About
LCA-Vision Inc./Lasik
Plus
®
LCA-Vision
Inc., a leading provider of laser vision correction services under the
Lasik
Plus
®
brand,
operates 75 Lasik
Plus
®
fixed-site laser vision correction centers in 32 states and 57 markets in the
United States and a joint venture in Canada. Additional company information is
available at
www.lca-vision.com
and
www.lasikplus.com
.
Earning
Trust Every Moment.
Transforming
Lives Every Day.
For
Additional Information
Company
Contact:
|
Investor
Relations Contact:
|
Barb
Kise
|
Jody
Cain
|
LCA-Vision
Inc.
|
Lippert/Heilshorn
& Associates
|
513-792-9292
|
310-691-7100
|
|
|
# # #